Kantilal Champaklal - Bellus Health CFO

BLU
 Stock
  

USD 9.30  0.06  0.65%   

  CFO
Mr. Kantilal Champaklal serves as Chief Financial Officer for GRP Limited. He has more than 30 years experience in Audit Financial Management Business Structuring and cost evaluation. His recent positions have been Finance Admin Manager Kvaerner Singapore Pte Ltd Management Business Consultant and Group Financial Controller Van Der Horst Holdings Pte Ltd . He serves on the boards of Luminor Capital Pte Ltd. Luminor Pacific Fund 1 Ltd. Luminor Pacific Fund 2 Ltd. and Platsearch N.L. .
Age: 61  CFO Since 2013      
450 680 4500  https://www.bellushealth.com

Bellus Health Management Efficiency

Bellus Health has Return on Asset of (19.8) % which means that on every $100 spent on asset, it lost $19.8. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (32.44) %, meaning that it generated no profit with money invested by stockholders. Bellus Health management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. Return on Average Assets is likely to drop to -0.44 in 2022. Return on Average Equity is likely to drop to -0.48 in 2022. Current Liabilities is likely to gain to about 18.3 M in 2022, whereas Total Liabilities is likely to drop slightly above 6.4 M in 2022.
The company has 871 K in debt with debt to equity (D/E) ratio of 0.0, which may show that the company is not taking advantage of profits from borrowing. Bellus Health has a current ratio of 14.93, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Bellus Health until it has trouble settling it off, either with new capital or with free cash flow. So, Bellus Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bellus Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bellus to invest in growth at high rates of return. When we think about Bellus Health's use of debt, we should always consider it together with cash and equity.
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people. Bellus Health (BLU) is traded on NASDAQ Exchange in USA. It is located in 275 Armand-Frappier Boulevard and employs 40 people. Bellus Health is listed under Pharmaceutical Products category by Fama And French industry classification.

Bellus Health Leadership Team

Elected by the shareholders, the Bellus Health's board of directors comprises two types of representatives: Bellus Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bellus. The board's role is to monitor Bellus Health's management team and ensure that shareholders' interests are well served. Bellus Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bellus Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Janine Eden, Group Company Secretary
Mahtani Bhagwandas, Independent Non-Executive Director
Jerry Vilakazi, Non-Executive Independent Director
Gary Harlow, Independent Non-Executive Director
Dean Suntup, Financial Director, Director
Mark Levy, Joint CEO, Executive Director
Brett Levy, Joint CEO, Executive Director
Chee Kwan, General Manager - Property Division
Laurence Nestadt, Independent Non-Executive Chairman of the Board
Kantilal Champaklal, CFO
Siok Lim, General Manager of Region Suppliers Pte Ltd.
Peck Peng, Financial Controller
Yusuf Mahomed, Independent Non-Executive Director
Joe Mthimunye, Independent Non-Executive Director
Cheng Tan, Company Secretary
Kevin Ellerine, Non-Executive Director
Tong Teo, Non-Executive Chairman of the Board, Non-Executive Independent Director
Peter Moe, Independent Non-Executive Director
Lik Goh, Independent Non-Executive Director
Phuti Mahanyele, Non-Executive Independent Director

Bellus Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bellus Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Bellus Health Investors Sentiment

The influence of Bellus Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bellus. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Bellus Health Implied Volatility

    
  90.46  
Bellus Health's implied volatility exposes the market's sentiment of Bellus Health stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bellus Health's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bellus Health stock will not fluctuate a lot when Bellus Health's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bellus Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bellus Health's short interest history, or implied volatility extrapolated from Bellus Health options trading.

Current Sentiment - BLU

Bellus Health Investor Sentiment

Greater number of Macroaxis users are currently bullish on Bellus Health. What is your opinion about investing in Bellus Health? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Pair Trading with Bellus Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bellus Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellus Health will appreciate offsetting losses from the drop in the long position's value.

Bellus Health Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Bellus Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bellus Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bellus Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bellus Health to buy it.
The correlation of Bellus Health is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bellus Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bellus Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bellus Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Bellus Health information on this page should be used as a complementary analysis to other Bellus Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Bellus Stock analysis

When running Bellus Health price analysis, check to measure Bellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellus Health is operating at the current time. Most of Bellus Health's value examination focuses on studying past and present price action to predict the probability of Bellus Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bellus Health's price. Additionally, you may evaluate how the addition of Bellus Health to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Is Bellus Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellus Health. If investors know Bellus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellus Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
992.8 M
Return On Assets
-0.21
Return On Equity
-0.34
The market value of Bellus Health is measured differently than its book value, which is the value of Bellus that is recorded on the company's balance sheet. Investors also form their own opinion of Bellus Health's value that differs from its market value or its book value, called intrinsic value, which is Bellus Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellus Health's market value can be influenced by many factors that don't directly affect Bellus Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellus Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bellus Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellus Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.